Education
About Us
Working with TipRanks
Follow Us
Silo Pharma (SILO)
NASDAQ:SILO
Total Valuation
Silo Pharma has a market cap or net worth of $5.05M. The enterprise value is ―.
Market Cap$5.05M
Enterprise Value―
Share Statistics
Silo Pharma has 4,484,456 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,484,456
Owned by Insiders4.19%
Owned by Institutions0.23%
Financial Efficiency
Silo Pharma’s return on equity (ROE) is -0.87 and return on invested capital (ROIC) is 347.12%.
Return on Equity (ROE)-0.87
Return on Assets (ROA)-14.63
Return on Invested Capital (ROIC)347.12%
Return on Capital Employed (ROCE)3.47
Revenue Per Employee24.03K
Profits Per Employee-1.46M
Employee Count3
Asset Turnover0.24
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Silo Pharma is -0.75. Silo Pharma’s PEG ratio is 0.89.
PE Ratio-0.75
PS Ratio94.92
PB Ratio0.65
Price to Fair Value0.65
Price to FCF-0.85
Price to Operating Cash Flow-0.85
PEG Ratio0.89
Income Statement
In the last 12 months, Silo Pharma had revenue of 72.10K and earned -4.39M in profits. Earnings per share was -1.19.
Revenue72.10K
Gross Profit66.26K
Operating Income-4.71M
Pretax Income-4.39M
Net Income-4.39M
EBITDA-4.71M
Earnings Per Share (EPS)-1.19
Cash Flow
In the last 12 months, operating cash flow was -3.83M and capital expenditures 0.00, giving a free cash flow of -3.83M billion.
Operating Cash Flow-3.83M
Free Cash Flow-3.83M
Free Cash Flow per Share-0.85
Dividends & Yields
Silo Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.08
52-Week Price Change-38.30%
50-Day Moving Average1.27
200-Day Moving Average1.30
Relative Strength Index (RSI)46.04
Average Volume (3m)104.08K
Important Dates
Silo Pharma upcoming earnings date is Nov 11, 2021, TBA Not Confirmed.
Last Earnings DateInvalid Date
Next Earnings DateNov 11, 2021
Ex-Dividend Date―
Financial Position
Silo Pharma as a current ratio of 4.29, with Debt / Equity ratio of 0.00%
Current Ratio4.29
Quick Ratio4.29
Debt to Market Cap0.00
Net Debt to EBITDA0.83
Interest Coverage Ratio925.59
Taxes
In the past 12 months, Silo Pharma has paid -4.39M in taxes.
Income Tax-4.39M
Effective Tax Rate0.00
Enterprise Valuation
Silo Pharma EV to EBITDA ratio is 0.13, with an EV/FCF ratio of 0.16.
EV to Sales-8.74
EV to EBITDA0.13
EV to Free Cash Flow0.16
EV to Operating Cash Flow0.16
Balance Sheet
Silo Pharma has $8.02M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$8.02M billion.
Cash & Marketable Securities$8.02M
Total Debt$0.00
Net Cash-$8.02M
Net Cash Per Share-$1.79
Tangible Book Value Per Share-$0.18
Margins
Gross margin is -371.65%, with operating margin of -6526.44%, and net profit margin of -6092.59%.
Gross Margin-371.65%
Operating Margin-6526.44%
Pretax Margin-6092.59%
Net Profit Margin-6092.59%
EBITDA Margin-6526.44%
EBIT Margin-6099.64%
Analyst Forecast
The average price target for Silo Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―